Hong Kong Exchanges and Clearing Limited and the Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.

山東威高集團醫用高分子製品股份有限公司

Shandong Weigao Group Medical Polymer Company Limited *

(a joint stock limited company incorporated in the People's Republic of China with limited liability)

(Stock Code: 1066)

PROPOSED AMENDMENT OF THE ARTICLES OF ASSOCIATION

This announcement is made by Shandong Weigao Group Medical Polymer Company Limited (the "Company", together with its subsidiaries, the "Group") pursuant to Rule 13.51(1) of the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited.

(1) THE PROPOSED AMENDMENT

The Company proposes to amend Article 14 of its articles of association by the addition of the underlined and bold text as set out below (the "Proposed Amendment").

*For identification purpose only

The original "Article 14 Scope of operations: production and sale of medical polymer materials and products, plastic products (exclusive of agricultural film), sanitary raw and auxiliary materials, extracorporeal circulation and blood processing equipment, syringe and puncture devices, equipment and devices in the operation room, first-aid room and treatment room, clinical examination and analysis instruments, electronic devices, physiotherapy and rehabilitation equipment, medical cryotherapy, low temperature and refrigeration equipment and devices; production and sale of large-volume injection (including blood preservative solution), in vitro diagnostic reagents, medical test and basic equipment, implant materials and artificial organs, interventional equipment, medical suture materials and adhesives, basic surgical instruments, dental surgical instruments, abdominal surgical instruments, urinary anorectal surgical instruments, medical optical instruments & apparatus and endoscopy devices, medical ultrasonic instruments and relevant devices, physiotherapy and rehabilitation equipment, medical X-ray equipment, ward nursing equipment and instruments, disinfection and sterilization equipment and instruments, medical cold therapy, cryogenic refrigeration equipment apparatus, dental materials, production and sale of moulds; sale of medical equipment and accessories, disinfectants, and disinfection apparatus; general cargo warehousing; general cargo road transport; wholesale and retail of medical disinfection products, hygiene products, daily necessities, cosmetics, packaging materials, instruments and meters, environmental monitoring equipment, hardware and electrical appliances, home appliances, computers, computer software and auxiliary equipment, computer consumables, general mechanical equipment and electronic products; leasing and repair of mechanical equipment accessories and electronic products and technical service consultancy; network technical services; import and export of goods, import and export of technologies (excluding the distribution business of imported goods); medical supplies, pharmaceuticals, food, agricultural products, cosmetics, health products, such as irradiation sterilization, disinfection and treatment; irradiation technology consulting services; operation of special medical vehicle (blood collection, ambulance, physical examination) (Business projects that are subject to approval in accordance with law may only carried out after the approval of the relevant departments)"

To be amended as:

"Article 14 Scope of operations: production and sale of medical polymer materials and products, plastic products (exclusive of agricultural film), sanitary raw and auxiliary materials, extracorporeal circulation and blood processing equipment, syringe and puncture devices, equipment and devices in the operation room, first-aid room and treatment room, clinical examination and analysis instruments, electronic devices, physiotherapy and rehabilitation equipment, medical cryotherapy, low temperature and refrigeration equipment and devices; production and sale of large-volume injection (including blood preservative solution), in vitro diagnostic reagents, medical test and basic equipment, implant materials and artificial organs, interventional equipment, medical suture materials and adhesives, basic surgical instruments, dental surgical instruments, abdominal surgical instruments, urinary anorectal surgical instruments, medical optical instruments & apparatus and endoscopy devices, medical ultrasonic instruments and relevant devices, physiotherapy and rehabilitation equipment, medical X-ray equipment, ward nursing equipment and instruments, disinfection and sterilization equipment and instruments, medical cold therapy, cryogenic refrigeration equipment apparatus, dental materials, production and sale of moulds, sale of medical equipment and accessories, disinfectants, and disinfection apparatus; general cargo warehousing; general cargo road transport; sale of medical disinfection products, hygiene products, daily necessities, cosmetics, office supplies, office equipment, office equipment consumables and stationery supplies, sale of office equipment and consumables, wholesale and retail of packaging materials, instruments and meters, environmental monitoring equipment, hardware and electrical appliances, home appliances, computers, computer software and auxiliary equipment, computer consumables, general mechanical equipment and electronic products; leasing and repair of mechanical equipment accessories and electronic products and technical service consultancy; network technical services; import and export of goods, import and export of technologies (excluding the distribution business of imported goods); medical supplies, pharmaceuticals, food, agricultural products, cosmetics, health products, such as irradiation sterilization, disinfection and treatment; irradiation technology consulting services; operation of special medical vehicle (blood collection, ambulance, physical examination) (Business projects that are subject to approval in accordance with law may only carried out after the approval of the relevant departments)"

  • (2) REASONS FOR THE PROPOSED AMENDMENT

    The Proposed Amendment will allow the Company to diversify the range of products that it may offer.

  • (3) ANNUAL GENERAL MEETING

    The Proposed Amendment is subject to the approval by the shareholders of the Company by way of a special resolution and the approval, registration and filing with the relevant government authorities of the People's Republic of China.

    The annual general meeting (the "AGM") for the shareholders of the Company to approve the Proposed Amendment is scheduled to be held on Monday, 24 May 2021.

    A circular containing further details of the Proposed Amendment, together with the relevant notice of the meeting and a proxy form, will be despatched to the shareholders of the Company in due course.

  • (4) CLOSURE OF REGISTER OF MEMBERS

    For the purpose of determining the list of shareholders of the Company who are entitled to attend and vote at the AGM, the register of members of the Company will be closed from Monday, 17 May 2021 to Monday, 24 May 2021 (both days inclusive). No transfer of Shares will be registered during this period.

    In order to qualify for attending the AGM, shareholders of the Company should ensure that all transfer documents, accompanied by the relevant share certificates, are lodged with the Company's H share registrar, Tricor Standard Limited at Level 54, Hopewell Centre, 183 Queen's Road East, Hong Kong, for registration no later than 4:30p.m. on Friday, 14 May 2021.

By Order of the Board

Shandong Weigao Group Medical Polymer Company Limited

Long Jing

Chairman

Hong Kong, 30 March 2021

As at the date of this announcement, the Board comprises:

Mr. Long Jing (Executive Director)

Mr. Chen Lin (Non-executive Director)

Mr. Tang Zhengpeng (Non-executive Director)

Mr. Lo Wai Hung (Independent non-executive Director)

Mrs. Fu Mingzhong (Independent non-executive Director)

Mrs. Wang Jinxia (Independent non-executive Director)

Attachments

  • Original document
  • Permalink

Disclaimer

Shandong Weigao Group Medical Polymer Co. Ltd. published this content on 30 March 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 30 March 2021 11:10:00 UTC.